Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Galaxy MedicareNSE:GML -1.68%19 3-Year ROIIC % is 24.23 as of Mar. 2026, which is at its 10-year median of 24.23. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Galaxy Medicare ranks better than 73.21% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Galaxy Medicare's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 24.23%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Galaxy Medicare's 3-Year ROIIC % or its related term are showing as below:
NSE:GML's 3-Year ROIIC % is ranked better than 73.21% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs NSE:GML: 24.23
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Galaxy Medicare 3-Year ROIIC % Related Terms
Galaxy Medicare 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Galaxy Medicare's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GML vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Galaxy Medicare's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galaxy Medicare 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Galaxy Medicare's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Galaxy Medicare (NSE:GML) has a 3-Year ROIIC % of 24.23 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Galaxy Medicare and its competitors. This is near median its historical median of 24.23. Over the past decade, Galaxy Medicare's 3-Year ROIIC % has ranged from 24.23 to 24.23. According to the industry distribution chart, Galaxy Medicare ranks #213 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 26.8%.
Is Galaxy Medicare's 3-Year ROIIC % too high?
Galaxy Medicare's current 3-Year ROIIC % of 24.23 is near median its 10-year median of 24.23. Over the past 10 years, this metric has ranged from a low of 24.23 to a high of 24.23. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Galaxy Medicare's value of 24.23 is 1548.3% above this industry median. Based on the distribution chart, Galaxy Medicare ranks #213 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #213 out of 795 companies for 3-Year ROIIC %. This puts Galaxy Medicare in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. Galaxy Medicare's value of 24.23 is 1548.3% above this benchmark. Historically, Galaxy Medicare's own 3-Year ROIIC % has ranged from 24.23 to 24.23 over the past decade. While the company's 10-year median is 24.23 vs. the industry median of 1.47, Galaxy Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current 3-Year ROIIC % of 24.23 is 1548.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current 3-Year ROIIC % is 24.23, which is near median its own 10-year median of 24.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current 3-Year ROIIC % of 24.23. The current 3-Year ROIIC % is 24.23, which is near median its 10-year median of 24.23 and 1548.3% above the Medical Devices & Instruments industry median of 1.47. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current 3-Year ROIIC % is 24.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score
Get the complete analysis for NSE:GML
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GML has been successfully added to your 
